This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Regor Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kate Xin Wen - Innovator in Pharmaceutical Research
Introduction
Kate Xin Wen is a prominent inventor based in Shanghai, China. She is currently associated with Regor Pharmaceuticals, Inc., where she contributes to innovative research in the pharmaceutical field. Despite having no granted patents to her name, her work is focused on developing compounds that have the potential to treat serious diseases.
Latest Patent Applications
Kate's latest patent applications include "HPK1 INHIBITORS AND USES THEREOF." This invention provides a compound represented by structural formula (I) or formula (II), or a pharmaceutically acceptable salt or a stereoisomer thereof, which is useful for treating diseases, such as cancer, that are treatable by inhibiting HPK1 activity. Another application under the same title presents a compound represented by structural formula (I-0) or formula (II), also aimed at treating diseases by inhibiting HPK1 activity.
Conclusion
Kate Xin Wen is making significant strides in pharmaceutical research, focusing on innovative solutions for treating critical health issues. Her contributions, although not yet reflected in granted patents, showcase her dedication to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile